GNI Successfully Completes IPO
TOKYO--(BUSINESS WIRE)--GNI Ltd., a drug discovery/pharmaceutical company in Asia, announced it has successfully completed an offering of new shares in connection with the company’s listing on the Mothers market of the Tokyo Stock Exchange on August 31. A total of 10 million shares were issued at 90 yen per share.